



LINEAR LIBRARY I 
C01 0068 4083 
I U II II I IIIII I ) 
TRANSITION METAL COMPLEXES OF · TETRACYCLINE$. 
by 
David Graham Cunningham. 
A THESIS PRESENTED TO THE UNIVERSITY OF 






















The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 













The research vhich is the subject of this thesis, vas carried 
out between March 1971, and September 1973, in the Chemistry Departmeat 
of the University of Cape Tow, and the Science Department of the 
Cape College for Advanced Technical Education. This vork has not been 
submitted to any other University. 
I vould like to thank Professor E.c. Leisegaag for his kiad 
assistance at all tilles. I vould like to express ~ deep appreciation 
(i) 
for the valuable assistance given to me by my first supeniaor, Mr. M.B. Pay, 
and especially my second supervisor, Dr. G.V. Fazakerley, tor his helpful 
guidance and patience. I also gratefully acknowledge the advice aad 
interest obtained from Dr. P.W. Linder. 
I am indebted to Mr. A.C. du Toit, Head of the Science 
Department of the Cape College for Advanced Technical Education, for 
the facilities he provided for this work; and to many friends for 
their encouragement. 
Chemistry Department, 




Fort.yaone transition metals vere studied to observe their 
complexing properties vith the tetracyclines. 
Four metals vere found to form sufficiently strong complexes with 
the tetracyclines to provide a basis for a rapid, reliable method of 
aBS&Jing the potency of the tetracycline products used in medicine to-d~. 
Microbiological methods take twenty hours to perform; spectrophotometric 
methods m$J be completed vithin one hour~ Tventy-eigbt of the tr&Dsition 
metals showed evidence of c011plex formation with the tetracJcliBesJ aot all 
of these complexes were found to be suitable for the spectrophotometric &SS$J 
of the tetracyclines, however. 
The ligaad--.tal ratios of some of the tranaitioD metal-tetracycline 
complexes were determined under specified conditions us!Qg Job's method. In 
the concentration range for ligand and metal (' x lo-5 M), the 1 : 1 com-
plexes appeared to predominate. 
Attempts were made to identify the binding sites of the metal ions 
on the tetracycline molecules, using infra-red spectrophotometr.rt but the 
results were inconclusive. 
The stability constant of one of the transition metal-tetracycline 
complexes was determined by a potentiometric method. 
Using this method, the result for the titanium·tetracycliae complex 
15 -1 was ~l • 3,4 x 10 M • 
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C H A P T E R I. 
1.1. Introduction. 
During the past twenty years, the practice of medicine has been 
greatly assisted by the use of antibiotics of the tetracycline series~ 
The three tetracyclines in common use are 
1. Tetracycline hydrochloride 
2. Oxytetracycline hydrochloride 
3. Chlortetracycline hydrochloride 
Their biological activities and physico-chemical properties have 
been extensively investigated over this period. 
Control laboratories throughout t~e world at present, assay 
medicinal products containing the tetracyclines by the microbiological 
method. This method is official in the British Pharmacopoeia 1968, and 
the United States Pharmacopoeia XVIII. The method takes approximately 
twenty hours to perform. 
Some short-comings of the method (e.g. Time) have stimulated eome 
workers to develop more rapid and precise methods for the quantitative 
analysis of the tetracyclines. These methods include column chromatography, 
paper chromatography, non-aqueous titration, fluorimetry1 and u.v. Spectro-
scopy. 
The tetracyclines (Table 1.1) comprise a group of antibiotics 
characterised by their common hydronaphthacene skeleton. Chlortetracycline 
was the first of the group to be isolated: it was discovered among the 
metabolites of Streptomyces aureofaciens 
'2 
in 1947 by Duggar. A few years 
2 . '. 
later 5-oxytetracycline was isolated by Finlay et al from Streptomyces 
rimosus fermentations. 
Tetracycline was first prepared by hydrogenolysis of 7-chlor-
tetracycline2, and shortly thereafter by fermentation processes using · 
certain media, low in chloride and from special strains of streptomycetes. 




2 th was lsc.overe , among e mutant strains of s. aureofaciens. 'All tJ::>,ese 
tetracyclines are· very useful in the treatment of clinical and ·yeterinarr 
infections, and taken as a group, are the most widely used antibi_otics- after 
the penicillins • 
All the tetracyclines are amphoteric, and many crystalline salts 
vii th strong acids and strong bases have been prepared. Each tetracycline 
has three ionisable groups, with pKa' s ranging from about 3, 3 to 9, 7. They 
have a common chromophoric system which gives rise to characteristic 
absorption spectra that extend:: into the visible region, imparting a yellow 
colour to all members of the family. 
The tetracyclines have characteristic fluorescence spectra as well; 
and this property is the basis of very sensitive analytical methods. The 
tetracyclines form chelates with many metal ions and this _reaction is t}1ougllt 
. ' . . .. '2 
to be responsible, in part, for their antibacterial activity. 
One method which has been devised for the isolation of pure 
tetracyclines from fermentation media, is the precipitation of calcium or 
magnesium complexes, extraction with butanol or other solvents, or extraction 
with carrier plus non-aqueous solvents. Since some of the fermentation 
procedures result in the production of mixtures of the tetracyclines, such as 
chlortetracycline· plus tetracycline, considerable care is used in the final 
purification steps to eliminate or minimize the minor impurities. 
The tetraCyclines have a wider range of antibacterial aotivi ty than 
any other known antibiotic. They are aoti ve ag&.ti'ISt many speciett of Grazn-,. 
positive and Gram-negative bacteria, spirochaetesr rickettsia and some of th~ 
larger viruses. Among bacterial spP.cies,. Gram-pos.i tive .organisms and the 
Gram-negative cocci are for the most part rather more susceptible than the 
Gram-negative bacilli. Notable exceptions are. Proteus and Pseudomonas 
aeruginosa, which are almost invariably resistant ;in vivo to these compounds • 




In Vitro Antimicrobial Activi tl of Some Tetrac;y;lines 
Microorganism Minimal inhibitory concentration (pg/ml) 
Ch1ortetra- Oxytetra- Tetra-
cycline cycline cycline 
Staphylococcus aureus 3 0,55 0,21 
~treptococcus pyogenes 0,6 0,07 o,o6 
Diplococcus pneumoniae 0,07 0,09 
Ae~obacter aerogenes 25 3 1,7 
Escherichia coli 12,5 1 0,73 
Proteus vulgaris 12,5 >100 '::> 100 
Proteus morganii ::::- 400 2 2 
Pseudomonas aeruginosa > 400 6 10 
Salmonella typhosa 1?,5 3 1,6 
Klebsiella pneumoniae 12,5 2,5 1,6 
Shigella .sonnei 5 5 2,5 
Vibrio comma 50 0,55 0,58 
Pasteurella mul~ocida 0,2 0,47 0,31 
6-Demethyl- 6-Methylene- 6-Deoxy-
7 -chlortetra- 5-hydroxy-tetra- 5-hydroxy-
eye line eye line tetracycline 
Staphylococcus aureus 0,11 0,13 0,19 
Streptococcus pyogenes 0,04 0,03 0,04 
Diplococcus pneumoniae 0,03 0,04 0,02 
Aerobacter aerogenes 0,35 0,94 2,5 
Escherichia coli 0,33 0,43 1,7 
Proteus vulgaris 90 ..::> 100 :> 100 
Proteus morgan!! 0,78 2,2 4.4 
Pseudomonas aeruginosa 3 6,3 ?,3 
Salmonella typhosa 0,55 1,4 1,6 
Klebsiella pneumoniae 0,55 1,6 ' 1,9 
Shigella sonnei 1,4 1,6 ?.,2 
Vibrio comma 0,17 0,29 0,31 
Pasteurella mul toCida 0,16 0,16 0,20 
4 
After oral administration of the tetracycline hydrochlorides, they 
are incompletely and irregularly absorbed from the gastro-intestinal tract. 
Absorption is diminished by calcium, magnesium, aluminium and other alkaline 
metals~ 
After absorption, the tetracyclines diffuse into body fluids; 
they are bound in varying degrees to plasma protein and are slowly excreted 
in bile ~d urine. Twenty to twenty-five percent of an orally administered 
dose and.fifty percent of an intravenous dose is excreted in urine. Serum 
concentrations of the tetracyclines range from 1 - 3 ;'Ug/ml, following a 
dosage of 250 mg every six hours~ 
Tetracycline hydrochloride. 
This occurs as a yellow, odourless, hygroscopic, crystalline, 
amphoteric powder with a bitter taste1· A one percent solution in water has 
a pH of 1,8 to 2,8. It is soluble (10,9 gje) in water; solutions become 
turbid on standing owing to hydrolysis and the precipitation of tetracycline. 




0 OH 0 
Tetracycline ·hydrochlori.(le is the hydrochloride of 4-dimethyl-
amino-11414a15,5a,6,11,12B.-octahydro-3,6,1G,l2,12a-penta-hydro:xy-6-methyl-
d~oxonaphthacene-2-carboxamide, which may be obtained by the catalytic 
reduction of chlortetracycline or by the growth of certain strains of 
Streptomyces aureofaciens. 
Oxytetracycline hydrochloride. 
This occurs as a yellow, odourless, hygroscopic, crystalline· 
powder with a bitter taste? It is soluble (500 gje) in water, in 
5 
ethanol (11 gje), and in methanol (11 gje )1 Solutions in water deteriorate 
when the·pH is less than 2, and are also rapidly destroyed by alkalies? 
Solutions in water should be stored in a cool place and used within 28 hours? 
Oxytetracycline has the same antimicrobial action and uses as 
described for tetracycline hydrochloride~ 
CO•Ht\ 
HCI 
Oxytetracycline hydrochloride is the hydrochloride of 4-dimethyl-
amino-1,4,4a,5,5a,6,11,12a,-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-
1,11-dioxonaphthacene-2-carboxamide, an antimicrobial substance produced bf1he 
growth of certain strains of Streptomyces rimosus. 
Chlortetracycline Hydrochloride. 
Chlortetracycline (Aureomycin) was isolated from a culture of 
Streptomyces aureofaciens: Oxytetracycline was isolated two years later 






Chlortetracycline hydrochloride is the hydrochloride of 7-chloro-
4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-
6-methyl-1,11-dioxonaphthacene-2-carboxamide, an antimicrobial substance 
produced by the growth of certain strains of Streptomyces aureofaciens or by 
any other means1 
It occurs as a yellow crystalline substance, odourless and 
possessing a bitter taste. It is soluble at 20 cr: in water (9 gje) and in 
methanol (17,4 gje). Solutions in water are fairly stable when refrigerated; 
but at 37 ~, they lose about 50% of their activity in 24 hours: 
Chlortetracycline hydrochloride has the same antimicrobial activity 
and uses described under tetracycline hydrochloride: The parent tetracycline 
isolated from StreptoiilJCeB albo-niger, was shown to be identical with the 
hydrogenolysis product of chlortetracycline! 
The tetracycline molecule posesses five asymmetric centres -
C-4,4a,5a,6,12a. A determination of the crystal E!tructure of chlortetra-
cycline hydrochloride has clearly defined the relative stereochemistry of 
8 these centres. 
The atructure-act!vitj relationship which prevails in the molecular 
architecture of tetracycline is fairly well defined. Functional grou,pa at 
positions 5,6 and 7 may be removed without altering the antimicrobial 
properties appreciably. Epimerisation at C-5a ~d C-4 or dehydrogenation 
at C-5a and C-lla results in the loss of activity. The natural oc con-
figuration at C-4 is essential. The hypothesis has been:advanced that th~ 
principal·active centre is the C-11, c-12 diketone systems of rings B. and C~ 




·~Q. q COKH 2 
OH 0 OH OH 0 
1 
The reactions that the tetracyclines undergo are generally of 
a sophisticated nature, which is due to the complex functionality ana the 
sensitivity of the mol~cules to very mild reaction conditions. 
An investigation into the absolute configuration of the tetra-
cyclines by V.N. Dobrynin et a18 led to the following result: 
Fig. 1.5. 
Rt ,Ra 






= H or Cl R~ = H or OH 
1.2. -The Medicinal Clleaistr;r of the !etraczclines. 
A solution of tetrac.rcline bfdrochloride in water becomes turbid 
on standiDg, 4118 to the hJdrol;ysia of tetr8C7cline h7drocllloride ani the 
precipitation of tetracycline (aolubilit.J 0,25 g/e). tetrac;ycline 
~chloride is stable in at.r but darkens iil moist air when expoaet to 
stroDg aunlisbt'. 
Tetrac;ycline ~drochloride on storage in the preseno6 of aoisture 
and heat toms two degradation products, epi~clrotetrac;ycline and. 
anh7drotetrac;ycline. The epimerisation occura at the C 
4 
at._. !etra-
c;ycline epiaerisea rapidl.J in aqueous butter solutioDB at pB :5 to 4• but 
more alowl;y above pB 6. At pB 2 to 6 tetrac;ycline will epimeriae, 
I 
produci.Dg 401' of epiaera in 24 hours. 
Oqtetrac;ycline epiaerises mach less relldil-7 than 'tetr&CJOl:iDI 
in aqueous aolutioa at )Ill 4• · 
_..... •'•. 
Solutions of chlortetrac;ycl1ne in water lose &bout ~ of their 
activitJ in 24 hours at 3-,:1 Deutral aDd alkaline solutions are r~idl;y 
inactivated'. 
The efficac1 with which an orally administered antibiotic is 
absorbed is not necessarily reflected in its serua concentration; some 
compounds are rapidly removed from circulation by the liver and appe·ar -m 
a high concentration in the bile. Re-absorption of tetracyclines which· 
have been preferentially concentrated in the bile m~ prolong its 
therapeutic activitJ. Chelation or the tetracyclines vitA aluminium, 
calciwa, aapesiUil and other divalent or trivalent cationS lll8J dele, or 
prevent their absorption after administration by mouta. 
The biological half-life or tetracycline is 8,5 hours, Chlor-
tetracycline 5,6 hours and oxrtetracycline 9,6 hours. 
1.3. Pharmacoiosz of the Tetracyclines 
1.3.1. Toxic effects of Tetracyclines 
The side-effects or tetracycline ~drochlorid.e adlliniate~d . :to 
patients are cOJUDon to all the tetracyclines& the)' include nausea, 
diarrhoea, and symptoms resulting from the overgrowtk of non-susceptible 
organisms}. The overgrowth or Candida albicans (a cODUJlon saprophJ'te in 
man) in the mouth causes soreness, redness and thrush, which. mar extend 
into the trachea and bronchi. Candida albicails overgrowtk in the 'bowels 
causes pruritis ani. The most serious supr~infection is b7 resietant 
staphylococci, causing a fulminating enteritis accompanied bJ d.ebydration 
and occasionally causing death3. 
Tetracrclines given to patients with renal disease, increase 
8 
the sever! tJ or azotaelllia w1 th increased excretion or ni trogea and loss or 
sodium. Occasionall7 severe and fatal liver daaase has occurred in 
pregnant women treated vi tla tetracrclinea. · TetracJclines are clepoai ted 
in calcif7ing areas in bone, in deciduous teeth, 8Dd. in the fiapr-nails 
and toe•nails causing discolouration. TetracrcliDes given to young infants 
or pregnant woaen, interfere vi th the growth or 'bones 1111d teeth in the 
infants3. 
Fifty-nine patients with tetracycline staining of the teeth 
were examined and it was found that those who had been given chlor-
tetracycline had grey-brown teeth, and those who had taken tetracycline 
or oxytetracycline had yellow teeth. On exposure to light, the yellow 
9 
teeth darkened to become brown in colour. The heaviest staining occurred· 
in patients on prolonged treatment with chlortetracycline, deaetqlchlor- · 
tetracycline and maternal tetraeycline}. The tetracyclines._, produce 
permanent brown or 7ellov pigmeiitation of the teeth and •B¥ caae 4Japluia. 
They readily cross the placenta ! and can affect the teeth of an unbora child 
it given to the mother in the latter half ot prepancr}. ()q'tetracycline 
I 
appears to be less Jaa.raf\ll thali 1 ts analogues, but the difterenees 'between 
th~ tetracyclines and the closes likely to be harmful are not 7et kilovn} •. 
T8tracycline bfdrochloride administered to tiye obstettic patients 
caused serious liver daaap and pancreatic qstunctioa: one ·p&tient ctied'. 
1.3.2. Toxicitt ot l>egredation Products ot Tetracycline•. 
TetracJCline bfdrochloride, in the presence of moisture and 
heat, forms the degradation products &bhydrotetracycline and epi&Dafdro-
tetracycline. '!'he degradation to epianhydrotetracycliDe is illllibited by 
the addition ot aodiwa hexametaphosphate; the latter prevents the pB falling 
below 2. The degradation products ot chlortetracycline are innocuous}. 
The only degradation product of the tetracyclines vhicla is toxic 8Dclis 
capable of producing renal lesions is epianhydrotetracycline'. Dle 
formation of epianhydrotetracycline troa tetracycline is accelerated by 
heat, humid! ty and. a low pB. 
Tetracycline products which contain these two epimere it given 
to patients can produce a Fanconi syndrome, vi th nausea, proteinuria, 
glycosuria, acicloais and vomiting within two or three d&JB of starting 
treatment}. 
10 
1.3.3. Antibiotic Classification 
The term antibiotic is general-ly restricted to substances produced 
in cultures during the growth of certain fungi or bacteria, or to sillilar 
substances produced, in whole or in part, synthetically, which even in very 
low concentrations, inhibit the vital processes or certainmicro-.organisms 
other, than the species producing them. 
These antibiotics •&J be broadly classified as tollows:-
























































6.. Antibiotics active against Entamoeba histolytica. 
Alninosidin Paramomycin 
Fumagillin Puromycin 
1· Antibiotics vitll anti-tullolir activity. 
Actinoaycins 
1.3.4. Antimicrobial action or Tetrecyclinea. 
The nwaber or different species and classes or micro•orgaaisJDS 
against which antibiotics are active varies with each iDdividual tetra-
11 
cycline. Some antibiotics s~ch as chloramphenicol 8Dd the tetracyclines 
are active against micro-organisms belonging to a vide variet7 or species, 
12 
not only bacteria, but also rickettsias, soae viruses, and even protozoa: 
these are termed broad-spectrum antibiotics. Others, such as benzyl., 
penicillin, are active against relatively few species of bacteria, and 
these are termed narrow.spectrum antibiotics, whilst others again have 
spectra which are intermediate in range. 
The terms bactericidal and bacteriostatic have been applied to 
antibiotics. A bactericidal antibiotic is one whick, in the concentration 
normally attained in the bodJafluids after therapeutic doses, has been 
shown by in vitro tests to kill the relevant microftorganisms, while a 
bacteriostatic antibiotic UDder similar circumstances inhibits the growth 
or the micro-organisiiS witkout killing it. An antibiotic waicll is 
bactericidal in a certain concentration •ar become bacteriostatic at 
lower concentrations. 
The distinction between bacteriostatic antibiotics which 
reverSibly iDhJ.bit the growth or susceptible micro-organis• 'bJ preventing 
bio-synthesis, and bactericidal antibiotics which kill the organisms by 
inhibiting a711thesis or their cell walls or cytoplasmic membrane is based 
on determinations of their effects in vitro on certain types of micro-
organisms. The tetracyclines are usually bacteriostatic in their action. 
Resistance to the tetracyclines develops relatively slowly in 
susceptible organis... Resistant strains or staphylococci, colifora 
bacilli, haellOqtic streptococci, pneumococci and Haeaophilus intluenzae 
have been reported}. An organiSJD which is resistant 1io one or the tetra ... 
cyclines is usually resistant to all other members or the group. 
1.}.5. Tetr!Qlcline Assars. 
The absorption or tetracyclines from the gut is dia!Dished by 
ailk, salts or calcium, iron, aagnesiwa and aluminium, ancl alkalies& 
therefore tetracyclines should not be given to patients who are receiving 
antacid therap;y. Magnesium sulphate administered vi th tetracJclines led 
to blood-levels approximately 25% or those observed without the salt}. 
These effects are due to metal tetracycline complexes being formed* 
13 
The presence of the two epimere, anhydrotetracycline and 
epianhydrotetracycline, in tetracycline is undesirable for two reasons. 
Firstly, they can produce the Fanconi syndrolll9 and otller toxic side•reactions 
with sometimes fatal results: secondly, they have a much lower antibiotic 
potency ( 6~) tha tetracycline. 
The aicrobiological assay of tetracycline will aot reveal the 
presence of tbeae eptmera specifically. 
> 
Forming a •tal-tetracycline 
complex with tetracycline and ass.,ing the product spectrophotometrically, 
will show the amount of pure tetracycline present and will also re-yeal the 
presence of the epi.Jiera or tetracycline if they are prelettt. !Jae apectro• 
photoaetric ass&J of tetracycline is therefore specific f•~ pUr& tetr~ 
cycline, and can also detect the presence or aDJ degradation prOducts. 
1.4. Stability Constants and Job's Method. 
Numerous techniques have been developed for determining the stability 
constants of complexes. These include the use of visible and ultraviolet 
spectroscopy, potentiometry, solubility properties, measurements of certain 
colligative properties such as freezing points or boiling points, vapour . 
pressure measurements and other methods. 
In this work spectrophotometry and potentiometry were used. 
In an aqueous solution containing a metal ion, M and a ligand, L, a 
series of complexes ML, ML2, ML; ••• M~ may co-exist in equilibrium with the 
hydrated metal ion and the ligand. 
M + L ML 
ML + 1 ML2 ; etc., 
to 
The equilibrium constants of these chemical reactions are called the 
formation constants or stability constants and are treated in detail in Chapter 
IV. 
The determination of formation or stability constants is of primary 
·importance in the study of complexes. It leads to the accumulation of data 
which in turn leads to a more comprehensive understanding of complexes and the 
relationships which govern their formation and structure. 
10 
Job's method· for determining the formulae of complexes formed 
between two components A and B is achieved by mixing equimolar solutions of A 
and B in varying proportions and measuring a property proportional to the 
concentration of the resulting solutions. Where coloured complexes are formed, 
the absorption of monochromatic light is frequently used. The difference (A), 
between each value of optical absorbance found, and the corresponding value 
were no reaction to have taken place, is plotted against the mole fraction of 
one of the components. Where the reaction is of the type A + nB ~ AB ; 
n 
the plot of Y against mole fraction of B should show a maximum or minimum 
(depending on whether the complex absorbs more or less than the individual 
components) corresponding to that mole fraction, X , of B where X = n max · max n+l• 
Thus n can be calculated. 
11 
Vosburgh and Cooper extended Job's treatment to systems in which 
two or more complexes are formed between A and B. They demonstrated that, 
when only a single compound is formed, the wavelength of the light used for the 
measurements can be selected arbitrarily. In this case, the value of X (mole 
fraction of B) at which Y is a maximum/minimum, remains constant independently 
of the wavelength used. When more than one compound is formed however, the 
value of X at which Y is a maximum/minimum varies with the wavelength. This 
provides a means for determining whether or not more than one complex is 
formed. If several complexes are forllied, the stoichiometries of the various 
complexes can be found by carefully selecting wavelengths at which to work. 
1.5. A Review of Research On Tetracycline, Oxytetracycline and 
Chlortetracycline Complexes With Metals. 
12 
A. Albert has determined the affinity of oxytetracycline and 
chlortetracycline for several metallic ions. He first detetermined the 
ionisation constants of these tetracyclines by potentiometric titrations and then 
15 
stability constants of the metal complex~s as shown in Table 1,2. 
Table 1.2. 
l·1etallic Oxytetracycline Chlorte tra.cycline 
cation log K 1 log K 1 ' log K 1 11 log K' log K 1 ~ log K' 1 ' 
Fe3+: 9,1 7,2 22 8,8 ?,2 21,6 
cu2+: 7,2 5,0 12,2 7,6 5,0 12,6 
Ni2+ 5,8 4,8 10,6 
Fe2+ 5,6 4,8 10,4 5,7 4,7 10,4 
2+· Co · 5,1 9 4,8 9 
Zn2+, 4,6 8 4,5 8 
Mn2+ 4,3 3,7 s,o 4,3 8 
The insolubility of some (2:1) metallic complexes, e.g~ Co, Zn, Mn, 
prevented the determination of the stepwise stabilit,y constants. I No attempts 
were made by Albert to determine the po~ition of the metal in relation to the 
tetracycline ligand. 
1 
This early work on the application of potentiometric measurements 
'." 
to the quantitative determination of metal-ligand interactions demonstrated 
the power of the technique. 
I 
T. Sakaguchi et al in Japan have prepared metal complexes of oxy-
tetracycline and chlortetracycline and determined their solubility and stability 
constants, using colorimetric methods. 
nitrates and sulphates of Th4+, uo2
2+, 
The metal salts used were the chlorides, 
Co2+, cu2+, Al3+ and zn2+. The 
solutions were prepared in water, ·ethyl alcohol or methyl cellosolve. The 
complexes were then precipitated by adding ether and purified by reprecipitatione 
The compounds they obtained were coloured powders or vitreous solids; most 
were water-soluble. The ligand: metal ratio for these complexes was found 
to be
1 
1 : 1, except zr4+ 1 : 2 and Fe3+ 1 : 2. Arranging the stability 
constants of these metal complexes in decreasing values gave the
1
following order: 
'3+ > zr4+ > T.h4+ ::> uo 
2+ ::> Al3+ '.? Mg2+ t•e 
2 
and Th4+ > cu2+ > Co2+ > z 2+-n _.. sr2+ 
These results confirm the results 
12 
obtained by Albert· to a large 
degree. 
16 
L.V. Dmitrienko et a113 have attempted to determine the sections of 
the molecule that may be involved in chelation. 
Fig. 1.6. ,--- - - - - --. I I 











I I . ,_...,.-
I 
























The information they gathered about the Bite& of ~toa&tiOa 
was obtained from infra-red spectroscopy studies. The latter also revealed 
the structure of the ions formed• They related dissociation constants of the 
tetracyclines with definite groups in the molecule. Their interpretations 
however are not unambiguous. They admit, that the interpretation of their 
results is a rather complicated problem, due principally to insufficient 
interpretation of the infra-red spectra of the tetracyclines. 
The infra-red spectra they obtained using KBr pellets contBined 
various tetracycline complexes prepared at pH 1,5, pH 5,3, pH 8,7 Bl'ld pH 11;0• 
These spectra are reproduced below. 
. . 
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F'ig. 1. 7. 
lOOr-------------------------------~~ 
Infrared spectra of specimens of TC in solid form (tablets 
with KBr) obtained from solutions with pH: l) 1,5; 2) 5,3; 3) 8,7 and 
4) ll. 
To overcome the difficulty of interpreting the infra-red spectra, 
only a few selected portions of the spectrogram were studied using standard 
compounds for this purpose. These compounds differed only slightly in 
structure from the tetracyclines; theywere tetracycline derivatives e.g. 
tetracycline nitrile. 
13 ' ' 
'l'he srune group of workers (L. V. Dmi trienko et al) . also found that 
for pK values of tetracycline, the I.R. spectra showed such changes as a 
characteristic enol shift through 30 - 40 cm-l to a lower frequency, and also 
a shift of an absorption peak from 1 670 to 1 640 cm-1, on passing from pH 1 
·to pH 5; these changes, they aver, indicate the dissociation of the tri-
carbonylmethane group, A. 
On increasing the pH from 3,3 to 7,5, the absorption zone at 1 230-
1 240 cm-l arising from the phenol hydroxyl group, is displaced to 1 260 
-1 
1 270 em • 
-1 A strong absorption band also then appears at 1 430 em ; this is 
due to the c11 ~ c12 grouping which forms a stable chelate ring. This is 
confirmed by. the absence of this band for isochlortetracycline, in which the 
phenol diketone group is destroyed. This evidence, they13 claim, allows the 
pK2 to be associated with group C. pK1 and pK3 
are associated with the 
. . · I . . ( I'\ l_ '·, ·' ~ ~.~, ; 
tricarbonylmethane and the dimethylammo~dum groups respectively •. 
18 
Cobalt (II) ::md nickel (II) complexes with the three tetracyclines 
were prepared and isolated by W.A. Baker et al~4. Their spectral and magnetic 
properties were then studied; the complexes were found to be octahedral, and 
the ligand: metal ratios were found to be 2 : 1. This ratio is in conflict 
with the results obtained by T. Sakaguchi et al. Careful study of the 
electronic spectra indicated that the molecules co-ordinated through oxygen: 
they suggest that this takes place in the 1,2,3 tricarbonylmethyl system. 
Calcium and magnesium complexes15 of tetracycline, oxytetracycline 
and chlortetracycline were studied using U.V. spectrophotometry. All these 
chelates were found to obey Beer's Law. 
rurther work on the structure of tetracycline complexes with metals 
has been done using metal complexes of tetracycline derivatives by T. Sakaguchi 
16 et al. Apo-oxytetracycline and iso•chlortetracycline were the two deriva-
tives used. Th and Zr chelates of oxytetracycline were hydrolysed with HCl 
to yield the apo-oxytetracycline chelates. u.v. Spectrophotometric studies 
carried out on these chelates ( ~ = 380 nm) suggested the phenolic ~-diketone 
group as the one responsible for chelation; either the 10 - 11 or the 11 - 12 
enol system. 
T. Sakaguchi et al17 studying the metal compounds of tetracycline 
derivatives, using infra-red spectrophotometry, reported the disappearance of 
the CO group of c11 , and the presence of the metal chelate in c11• 
Work on the complexing properties of oxytetracycline by T. Higuchi 
et a118 , and interactions in aqueous solutions with model compounds, metals, 
chelates and biochemicals have shown that there is a relation between activity 
as a complexing agent, and the position of functional groups.· Experiments 
with a number of non-aromatic compounds have indicated that aromaticity is 
essential for optimum complexing activity. 
The Lambert-Beer Law is obeyed in the u.v. spectrophotometric range 
for most metal-oxytetracycline complexes!9a 
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The phenol-diketone group (C) has been suggested as the chelating 
group in oxytetracycline derivatives (See lt,ig. 1.6. ). It appears to be either 
the 10 - 11 or the 11 - 12 system;3 In the case of the Zr chelate, both the 
. 16 
10 - 11 and the 12 - l systems may be involved. 
The complexes of oxytetracycline with so•etransition elements have 
been prepared and isolated. They are soluble in water and sparingly soluble 
in solvents such as ethyl alcohol, butyl alcohol, but insoluble in chloroform, 
benzene and ether. 
The following metals have been reported in the literature to 
form chelates with OX7tetracycline. 
Fe3+ Fe2+ cu2+ 
Co2+ Mn2+ Ni2+ 
Zn2+ Al3+ Th4+ 
M 2+ g uo2+ 2 zr
4+ 
ca2+ B3+ Bi 3+ 
Sb 3+ As 3+ 
HoweTer, complexes of Au, Cd, Cr, Co, Fe, MD, Ji, Ac, ZD, Sa, Se, 
Sr, Sb and Ca haTe been reported to coaplex with the aluminium cluconate-
tetracycline complex. 'l'hia mq be due to the tendency ot the aluadniwa 
chelate to chance rapidly into anbydrotetraoycline aluminium chelate when 
moist. 17 
In studying complexes of oxytetracycline with calcium and magnesium 
spectrophotometrically5, B. Duggar has observed that the binding of these 
metals with oxytetracycline occurs in a step-wise fashion. The calculation 
of the stability constants gave log K values of 3,0 and 2,0 for the 1 : 1 and 
2 : 1 calcium oxytetracycline complexes and log K, 3,6 and 2,4 for the 1 : 1 
<md 2 : 1 magnesium oxytetracycline complexes. It was postulated that still 
higher metal-ligand complexes may exist, but the 1 : 1 and 2 : 1 species 
predominated. 
20 
L.G. Chatten and S.l. Krausel9b, in studies on two of the 
degradation products of tetracycline, epianhydrotetracycline and 
anhydrotetracycline, have shown that complexation with some transition 
metals led to colour development in the same manner as undegraded tetra ... 
cycline. However, the coaplexed degraded tetracycline exhibited maximal 
absorbance at 485 na and, in fact, showed no absorbance at the wavelength 
used in the undegraded tetracycline ass&J procedure. 
The survey of tbe tetracycline complexes with the transition 
elements has served to confirm the metal : ligand ratio found by some 
workers2•15•5 (T. Sakaguchi, M. Amer et al, B.M .. Duggar), but is in conflict 
vi th other investigators 1 results. The value for the titaaiua-tetracycline 
complex dissociation constant obtained in this work is in accord witb results 
12 obtained b.J Albert for similar metal-tetracycline complexes. 
'f.he confirmation that the metal-tetracycline complexes obey Beer's 
Law, justifies the use of a spectrophotometric method for the quantitative 
estimation of the potency of tetracycline products. No workers have appeared 
to utilise X-ray diffraction methods to confirm the structure of the tetra-
cycline-metal complexes. Three dimensional Patterson syntheses should be of 
value in determining once and for all the absolute configuration of these 
complexes. 
The infra-red spectra obtained in this study of the tetracycline 
transition metal complexes, generally, showed few significant changes when 
compared with the tetracycline I.R. spectra. 
1.6. Objectives of the Research. 
In this work, the transition elements were studied to observe their 
complexing properties with the tetracyclines. 
Efforts were made to study the ability of those elements which 
formed complexes, to be adapted to provide a rapid, efficient, reliable method 
of assaying the potency, spectrophotometrically, of the tetracycline products 
marketed to-day. 
The specific! ty of the method was also examined., especially 
the detection of degradation products such as epianhydrotetracycline. 
The chemistry of the tetracycline-transition metal complexes 
wss studied intensiTely using infra-red and ultra-violet spectroscopy. 
Stoichiometric studies were used to obtain the ligand : metal ratios 
for some of these complexes. 
The method of continuous variation was used to determine tlle 
stability constants of some of these complexes. 
21 
C H A P T E R I I. 
2.1. Spectrophotometric detection of the Complexation of Tetracyclines 
with transition metal ions. 
Experimental. 
22 
A purified sample of tetracycline hydrochloride obtained from 
Ledlab Ltd., was used for the formation of the tetracycline complexes. 
Deionised water was used throughout this work. All laboratory glassware 
was cleaned under personal supervision; rinsed with hot water three times 
and then rinsed with cold water three times. 
Grade A glassware was used, graduated at 20 ~ and the laboratocy 
thermostatic air-conditioner was adjusted to maintain a temperature of 20~ 
throughout the working periods. 
The instrument used was a Beckman DB~ G u.v. Spectrophotometer. 
The following procedure describes a typical method of preparing a 
tetracycline-transition metal complex and was generally used for all the 
tetracyclines studied. 
Fifty milligrams of tetracycline hydrochloride was dissolved in 
about 10 ml of water in a small beaker, transferred quantitatively to a 50 ml 
volumetric flask and made up to volume with water. 0,375 ml of this solution 
was transferred to a 20 ml beaker and 1,25 ml of a O,Oll. M solution of the 
metal salt solution added. Ten ml of water was added and sufficient sod.Nl~Jl. 
acetate solution (10%) added to adjust the pH to 5,8 (usually + 1 ml)• The 
solution was then transferred quantitatively to a 25 ml volumetric flask and 
made up to volume with water. 
After allowing the mixture to stand for a period of ~hirty minutes, 
a sample was placed in a 1 em quartz cell, and using a matched reference cell 
containing water at the same pH (5,8), the sample was scanned in the u.v. 
spectrophotometer coupled to a recorder for the 500 - 190 nm range. 
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o, 375 ml of the tetracycline hydrochloride solution wns then pi petted into a 
20 ml beaker, and 10 ml of water added. 1be pH was adjusted to 5,8 using a 
10{.; solution of sodium acetate. 'lbe mixture was transferred quantitatively 
to a 2 5 ml flask (volumetric) and made up to volume with water. A sample was 
placed in a 1 em quartz cell, and using the same reference sample described 
above, the sample was scanned in the u.v. spectrophotometer coupled to the 
recorder for the 500 - 190 nm range. 
1,25 ml of a 0,01 M solution of the metal salt wa.S pipetted into 
a 20 ml beaker, and 10 ml of water added. Sufficient sodium acetate solution 
10}~ was then added to adjust the pH of the solution to 5.,8. The mixture was 
quantitatively transferred to a 25 ml volumetric flask and made up to volume 
with water. A sample was placed in a 1 em quartz cell and scanned in the 
u.v. spectrophotometer coupled to the recorder for the 500- 190nm range. 
(. 
The chart paper on which the absorption curves were obtained was 
semi-transparent, and thi-s property was explo'i ted by placing the three sheets 
of paper on top of each other; this facilitated the comparisons on a light 
box considerably. The curves were carefully studied. A pronounced 
bathochromic shift (:> 10 nm) of the normal tetracycline hydrochloride 
absorption peaks indicated the formation -of a complex in some cases. The 
disappearance of some tetracycline peaks also offered further evidence of 
complexation with the transition element. 
It was decided to choose four transition elements; one from each 
period, and investigate their complexation properties thoroughly, and hence 
assess their value as a means of assaying tetracycline hydrochloride spectre-
photometrically. 






2.2. Spectrophotometric Determination ofT~tra.cyclines. 
Cupric sulphate A.R. grade was used for the following experimental 
work. 
Calibration graphs were prepared using tetracycline Hydrochloride 
in five different dilutions as follows: fifty milligrams of tetracycline 
hydrochloride was dissolved in 10 ml of water. This solution was then trans-
ferred quantitatively to a 50 ml volumetric flask, and made up to volume with 
water. In five clean volumetric flasks were placed the following amounts of 
tetracycline hydrochloride solution. 
1. 0,125 ml, 
2. 0,25 ml, 
3. 0,375 ml, 
4• 0,50 ml, 
5. 0,625 ml. 
1,25 ml of a o,ol; M cupric sulphate solution was then pipetted into 
each flask, followed by 10 ml of water. Sufficient sodium acetate solution 
lqr~ was then added to each flask to adjust the pH to a value of 5,8. The 
flasks were then made up to volume with water, and set aside for a period of 
thirty minutes. 
Observations: 
The addition of the cupric sulphate solution to the tetracycline 
hydrochloride solution produced a very slight change in colour from yellow to 
a faint greenish yellow. On adding the sodium acetate solution, however, a 
pronounced change in colour took place as the green-yellow chelate was formed •. 
!he solutions in the fiaska were 'tlla ••8lllled 1a the u. Y. apectro-
photo•ter fro. 500 - 190 DID, uaiDg 1 ca' cells ... 'the . abaorpUitil OU'V.. . 
. . ...,._. 
•~talael • the reco1'der. 
olttat.aM hc1a the copper-tetracrclllle Cblf1es with tile pnta 1a the· 
uaorp·U• ....,.. et the tevac,-cllDe h)'droch1oride aolutioa, a Mrtaeelarclalo 
shift .t.Na 365 nm to 425 DID was observed, coUpled with the coaplete 
disappearance of the · secondar;r peak at 278 •· . 
25 
This new absorbance peak at 425 nm was then used to prepare a 
calibration graph from the five absorption curves obtained. These absorption 
curves appear in Appendix 1, and the calibration graph is shown in figure 2.3.; 
the tetracycline hydrochloride curve is shown in figure 2.1., and the cupric 
sulphate, tetracycline, and cupric sulphate-tetracycline complex curves in 
fig. 2.2. 
0amples of products containing tetracycline hydrochloride supplied 
by manufacturers in this country to hospitals throughout the Cape Province were 
thr~n nsso,ycd in the following manner, using cupric sulphate solution 0, 01 M, 
to determine the amount of tetracycline present. 
·,sxperimental. 
i 
l'etracycline hydrochloride Syrup (Spectromel - oral 'suspension supplied by 
;; • L. Laboratories). 
l1iethod. 
Dilute the syrup with sufficient water in order to obtain a solution 
containing 1 mg/ml of tetracycline hydrochloride. Pipette 0,375 ml of this 
solution into a 25 ml flask. Add 10 ml of water and sufficient sodium acetate 
solution 107£ to adjust the pH to 5,8. Add 1,25 ml of the cupric sulphate 
solution, 0, 01 M and make up to volume with water. Mix well and allow to 
stand for thirty minutes. Neasure the absorption in the U.V. spectrophoto-
meter at a wavelength of 425 DJI, using 1 em cells ami frora 1;be· o.,;l.i:b~ati:.an 
graph prepared, read off the concentration of tetracycline hydrochloride, 
and determine the potency of the syrup. 
Observations. 
The copper-tetracycline complex exhibited a slisbt negative 
absorbance value for the wave-length range ~80 - ~20 nm as shown in 
Fig. 2.2. Several of the transition metal tetracycline complexes gave 
a similar negative absorbance value at certain wave-lengths when scauned 
in the u.v. spectrophotometer. 
500 
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The complexation of cuprjc sulphate with degraded tetracycline 
gave the absorption curve shown in Fig~ 2.5. 
Degraded tetracycline gave the absorption curve shown in Fig. 
The detection of the presence of degraded tetracycline in the 
presence of tetracycline vas found to be much more discernible using 
thorium (Fig. 2.6.) than with copper. 
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Tetracycline hydrochloride vas degraded in the following manner. 
! one percent solution in water was adjusted to a pH of 1,0 with dilute 
hydrochloric acid, and heated at 6~ for eight hours. This solution was 
then diluted to contain 1 mg/ml with deionised water and then treated in 
the same way as the tetracycline solution described above before scanning 
in the u.v. spectrophotometer i.e. pH adjusted to 5,8 etc. 
Complexation of the degraded tetracycline solution with cupric 
sulphate was thep performed in. the same manner described above for pure 
tetracycline (See Fig. 2.5.) 
2. 3. ·.Microbiological Assay of Tetracyclines. 
The ·same tetracycline hydrochloride syrup was then assayed by the 
method given in the British fharmacopoeia 19681 
Method. 
'l'he potency of a sample of a tetracycline product is determined by 
comparing the dose which inhibits the growth of a suitable susceptible micro-
organism,in this case Bacillus pumilus N.C.T.C. 8241, with the dose of the 
.' 
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standard preparBtion of tetracycline which produces the same degree of in-
r1jbi tion. The standard tetracycline is:the dry powder·{hydrochloride) con .. 
taining 980 units per mg. A unit is the specific activity contained in such 
an amount of the relevant Standard Preparation as the Hedical Research Council 
may from time to time indicate1 The quantity is exactly equivalent to the 
unit accepted for international use where this has been defined1 
'rhe formula for the nutrient agar medium A is given below, 
Peptone 6 g 
Pancreatic digest of casein 4 g 
Yeast extract 3 g 
Beef extract ,1,5 g 
Dextrose 1 g 
Agar 15 g 
Water ad 1 000 rill 
The agar was dissolved in boiling water and the rest of the 
ingredients added. 'rhe pH was adjusted to a value of 6,6. 
A rectangular, sterile, glass tray 30 em x 30 em was filled to a 
depth of 4 mm under an aseptic screen, with the medium A, inoculated at 45 ~ 
with a 1% v/v suspension of Bacillus pumilus spores. The tray was fitted 
with spirit levels so that an exactly horizontal position was attained. The 
tray was allowed to cool to room temperature for a period of thirty minutes, 
Thirty-six small sterile porcelain cylinders, approximately 10 mm 
high and having an internal diameter of approximately 5 mm, were heated to a 
temperature of 150 ~ and placed on the surface of the inoculated medium in a 
rectangular pattern (6 x 6) and 3 em apart. 
Solutions of the standard preparation and solutions of the sample 
being tested were then prepared with sterile water at ,a pH of 5,8. 
The solutions were prepared in three strengths to give the following 
concentrations of tetracycline hydrochloride. 
1. 24 units/ml 
2. 12 units/ml 
3. 6 units/ml 
Notes on experimental work. 
The equipment used throughout this procedure was sterilised by 
28 
heating at 150 ~ for one hour. Aseptic techniques were used in all stages 
of the work. An aseptic room was used, equipped with ultraviolet germicidal 
lamps and a positive air pressure; hands and forearms were scrubbed with 
germicidal soaps and lotions for three minutes before commencing work. 
The solutions of tetracycline were then placed in the porcelain 
cylinders in a certain pattern (shown below), using sterile pipettes. Each 
cylinder received 0,3 ml of solution. 
The tray was then left at room temperature for two hours. It was 
then placed in an incubator at a temperature of 37 ~ for a period of sixteen 
hours. The tray was taken to a projection room and placed on an ·overhead 
projector. The image was focussed sharply on a screen, five metres away. 
The diameters of the zones of inhibition were carefully measured in milli-
metres and recorded. From the results, the potency of the sample being tested 
was calculated. 
The formula used was 
= 
£ d 2 - ki d I 2 kL d" ~ 
k
2 
- 2k - r + 2 
where , S • pote~cy of tetracycline sample 
r = total number of dilutions used (6) 
d'= the difference between the mean effect for a particular row and 
the grand mean 
d":!: the difference between the mean for a column and the grand mean 
k = number of rows = number of columns = 6 
N.C.T.C. is the National Collection of Type Cultures, obtained from 
the Central l~blic Health Laboratory, Colindale, London. 
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'l'he micro-organism Bacillus pumilus was obtained from this laboratory 
and spores were grown, suspended in sterile water and used throughout for the 
microbiological assays. 
Design of cylinders used for the microbiological assay. 
TL TH TL TM TH 
SL SM SH SL SM SH 
TL TM TH TL TM TH 
SL SM SH SL SM SH 
TL TM TH TL TM TH 
SL SM SH SL SM SH 
-------------
'r = sample of te tre.cyc line syrup tested 
'rL = sample of tetracycline syrup tested containing 6 units/ml 
T]\'i = sample of tetracycline syrup tested containing 12 units/ml 
'l'H = sample of tetracycline syrup tested containing 24 units/ml 
-------------
s = standard preparation of tetracycline hydrochloride 
SL standard preparation of tetracycline hydrochloride solution 6 units/ml 
SN standard preparation of tetracycline hydrochloride solution 12 units/ml 
SH standard preparation of tetracycline hydrochloride solution 24 units/ml 
The results of the assays of tetracycline, microbiologically and 










2.4. Summary of the Results of Spectrophotometric and Microbiological 
Assays. 
The results obtained from the experimental work described are 
shown below. More results are shown in Appendix 3. 
Absorption curves were obtained for the 28 transition element 
chelates with tetracycline hydrochloride and carefully studied in order 
to assess their usefulness in serving as a rapid means of assa,ying 
tetracycline preparations for their potency. 
The results are ·produced in Table 2 .1. 
The results of comparing the spectrophotometric assqs of the 
tetracyclines marketed in this country with the microbiological assqs are 





Metal Bathochromic Shifts 
Tetracycline Oxytetracycline Chlortetracycline 
Cadmium 5Jlll 4nm 7mi 
Cerium ... 40 nm (hypsochromic) 
+ Cobalt 
+ Copper 60 nm 30 nm 17 na 
Dysprosium 38 Dill 20 nil 20 Dll 
Erbium 25 lUI -
Europium 30 lUI -
Gold No marked absorption peaks 
+ . Iron 
Lanthanua 30 nm 20 Dll 19 illl 
+ Manganese 
Mercury - 25 Dll (bfpsochromic) -
Molybdenum 20 Dll •.. 
Neodymium 38 lUI 5ma . ,. 
+ . 
Nickel 
Palladiua 20- 20 nm 25 DJI 
Praseodymiua 25 Dll 30 Dll 30 Dll 
Rutheniua 10 Dll - 20 1111 (hypsochromic) 
Samarium 20 DJI 8nm 10 nm 
Silver 45 Dll -
Terbiwa - 10 DJI (hypsochroaic) -
+ Thoriwa 40 Dll 
Titaniwa 60 DJI -
Tungsten 30 Dll 30-
+ Uranium 
Vanadium 21 Dll 50 nm 
Yttrium 38 Dll 10 nm 10 Dll 
+ Zinc 
+ Zirconium 
!2!!= Metals marked + form coaplexes with tetracyclines which have b•en 








Spectromel (tetracycline syrup) 
M.L. Laboratories 
Tetramel (oxytetracycline 
syrup) M.L. Laboratories 



























Cadmium, praseodymium and uranium salts were then used to form 
complexes with some tetracyclines produced by pharmaceutical firms, and the 
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Cadmium 251 mg 
Praseodymium 248 mg 
· ·uranium 249 mg 
Cadmium 25,1 mg/ml 
Praseodymium 25,2 mg/ml 
Uranium 25,0 mg/ml . 
From the results given in Tables 2.2.· and 2.3., it will be seen that 
the spectrophotometric assays are in good agreement with the microbiological 
assays. The latter are obviously slightly cruder by ·their very nature, and to 
allow for this, the specifications of the British Pharmacopoeia and the United 
States Pharmacopoeia allow the limits of the labelled potency to vary from 90% 
to 1151~ or more. 
C H A ~ T E R III 
Structural Studies of Some of the Transition Netal-tetracycline complexes. 
,.1. Infra-red Spectrophotometric Studies. 
Hopes were held that it would be possible to differentiate between 
different possible binding sites in tetracycline by examining the characteristic 
vibration frequencies of these sites before and after chelation. 
The most probable sites that have been proposed are:-
(i) A (j keto-enol system and in particular, the C-11, C-12 
conjugated system which would be analagous to the common 
11ce t,y 1-nce tonll. te complexes. 
(ii) Between the keto group on C-1 and the adjacent urnide group. 
(iii) Between the hydroxyl group on C-3 and the adjacent amide 
group. 
It must be remembered that (ii) and (iii) probably represent a 
very simplified view of tetracycline. It has been proposed by Donohue et a1
20 
' 
on the basis of an abnormally long bond length in the keto group of the amide, 
that strong hydrogen bonding occurs between the keto group and the hydroxyl 
on C-3. Correspondingly the C-OH bond at C-3 is very short. 
Fig. ,.1.1. 
OH 






The spectrum of tetracycline hydrochloride in a nujol mull is 
shown ·in Figure .>1.2. From the complexity of the spectrum it is quite 
clear that definite assignment of any of the bands is not possible. (Nujol 
peaks are marked with an x). 
The near infra-red contains bands arising from the various hy~roxyl 
stretches and also the amide NH stretches. Extensive intra-molecular hydrogen 
bonding will both broaden the hydroxyl stretches and spread them over a wide 
range. The same is true for the NH stretch(es) as one of these protons m~ 
' . 
be hydrogen bonded to the keto group at C-1 (See Figure ,.1.1.). 
-1 . 
The region 1 500 - 1 700 em should encompass the C•O stretches 
and probably also the N-H bends. 
The lower region of the spectrum is too complex, although it misrt 
be possible to detect M-0 or M-N stretches between 200.- 600 cm·1• 
Differentiation between bonding to oxygen and nitrogen on the basis of I-R 
measurements is not possible. The spectra shown in Figures 3.1.3., 
The resolution is not particularly 
good in those regions where we hoped to obtain useful information. This 
poor resolution is found whether the complexes are prepared in nujol mulls, 
potassium bromide discs or dissolved in water. 
The region 1 500 - 1 700 em -l shows one change in all of the spectra 
of the complexes from that of tetracycline hydrochloride. The band at 
1 671 cm-1 in tetracycline hydrochloride either disappears or is very weakened. 
The spectra ~f the titanium and praseodymium complexes show1 the most 
pronounced effect. This rather high stretch may well arise from a conjugated 
keto s~stem such as that between C-11 and C-12 or C-1 and C-3. However, if 
chelation did occur through a ~-keto-enol system, then by analogy with the 
-1 acetyl acetonates we would expect the vibration to shift 30 - 80 em to 
lower frequencies. It is not possible to state definitely that this has 
. 6 -1 occurred because of probable overlap with the bands at 1 17 and 1 584 em • 
If chelation occurred via the amide-keto group we should also expect 
-1 the NH stretch to be reduced by ± 100 em • However; no significant changes 
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~6 
occur in the near intr.-red region and in any case we -.re unable to assign 
any vibration{s) to the JB2 moiety because or general broadenins. 
E!perimental. 
Spectra were recorded on a Perkin-Elmer 457 and a Beckaan I.R.-12 
intr--red spectrophotometer. The complexes were prepared as described 
previously from aqueous solutions. These solutions were examined in cells 
fitted with silver chloride windows. MBQY or the complexes prepare& were non-
crystalline and way in texture. It was not possible to prepare mulls or 
discs with these coaplexes. The latter are unfortunately, only soluble in 
hishly polar solvents which are unsuitable for I.R. spectroscop;y. fn f1Zf1 
case, it ma;r be that the complexes decompose on dissolution in these solvent&. 
In oder · to· investigate the binding site .. a tuncUOD of pB, 
coaplexes were p:repared at pB 1, 5,8 and 12, but no useful information was 
ob\ained. 
It is clear that with a complicated molecule such as tetracycline, 
infra-red studies will not give unequivocal information of the binding sites. 
}.2. Job's Method for Determining the Ligand-metal Ratio. 
In co-ordination chemistry complexes have been identified in solution 
without being isolated. For example, the interaction of Ni2+ with NH 3 in 


























+. In this series of complexes orily Ni(NH
3
)6
2+ has been isolated, 
but spectrophotometric and potentiometric investigations have shown that the 
other five complexes exist in solution. 
: 
The procedure which was used in determining the solution composition 
of the tetracycline-transition metal complexes is known as the method of 
continuous variations or Job's method. We are concerned with evaluating n 
for the equilibrium 
M + nL ...... ML 
< n •••••••••• ).2.1. 
where M is the metal and L the tetracycline ligand. 
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In the work described below, the intensity of absorption at a given 
wavelength of a series of solutions containing varying amounts of M and L are 
measured. This absorbance is related to the concentration of ML in solution. n 
•f.he solutions were prepared with the condition that the sum of the concentra-
tions of M and L were the same in all the solutions. In the case where the 
equilibrium constant for 3.2.1. is very large, the intensity of the ML n 
absorption will be greatest when the L concentration in solution is exactly n 
times greater than that of M. Sufficient concentrations of ML must, however, n 
be produced so that accurate absorbance measurements may be obtained with all 
the solutions. It is therefore possible to determine n and the composition 
of ML by knowing the ratio of L to M in the solution which contains a maximum 
n 
absorbance for ML • 
~ 
Assume that the substances MandL react according to equation 3.2.1. 
Equimolar solutions of M and L, each of B moles per litre concentration, are 
mixed in varying amounts so that the total concentration (M and L) is B. A 
series of these solutions may be prepared by the addition of X litres of L 
to (1- X) litres of M (where X< 1). The concentrations of M, L and filL 
n 
at equilibrium in these solutions are designated c1 , c2 and c3 respectively. 
Thus for any solution the concentrations are expressed as follows 
cl "' B (1 - X) - c3 
......... 
c2 .. Bx: - nc3 . ......... 
n c .. JC.ClC2 . ........ 3 
where K is the equilibrium constant for reaction 3 .2.4. 
a maximum in the curve c
3 
plotted versus X is that . 
d c3 · 
dX = 0 ......... 
3 .2.2. 
3 .2.3. 
3 .2.,4 • 
The condition for 
3. 2. 5. 
Differentiation of equations 3.2.4., 3.2.3. and 3.2.2. with respect 
to X, and combination of the three resulting dirferential equations with 
. equations 3.2.2., 3 .2.3. and 3.2.5. gives 
A. 
n = 1 - X I I I I I e I I • 3.2.6. 
}~ 
'rherefore from the value of X for which C~ is a maximum, n may be 
calculated from equation }.2.6. 
It can be shown that a maximum in the absorbance at a given wave-
length of light when X is varied coincides with the maximum of c3• 
From the Beer-Lambert Law 
A = E ce .......... }.2.7. 
where A "' absorbance 
E. = molar extil'l.ction coefficient 
e = path-length of cell 








respectively. Since the absorption of a solution is the sum 
of the absorbances at that wavelength of the contained species, the measured 
absorbance, A meas., is given by the relationship, 
A me as. = ( f 1 c1 + E 2 c2 + £ 3 c3) • • • • • • • • • • }. 2 .e. 
If there is no interaction between l1 and L, c
3 
= O, the absorbance 
~ + 1 would be 
~ + L = [ £ l B (l - X) + f 2 B X] e . . . . . . . . . . 3.2.9 • 
where B is the molar concentration of the M and L solutions. 
The difference between A meas. and A,..,. + I is designated Y. 
~ J . J 














.Is (l - x) :- E 2 B x] e }.2.10. 
By differentiation of equation ).2.10 with respect to X it can be 
shown that Y is a maximum when C 
3 
is a maximum if E 
3
> f 1, or a minimum when 
c
3 
is a maximum if E 
3
< £1• 
To evaluate n in ML , a plot of Y (ordinate) versus X (abscissa) 
n 
at a given wavelength is made. A maximum in this plot qccurs at a certain X 
mole fraction. From this value of X, n may be calculated from equation 3.2.6. 
· Equimolar sol~tions of tetracycline hydrochloride and titanium 
chloride.were prepared. Th'e concentration was 0,3 x 10-5 molar. Where [M] 
is the concentration of the metal and [T] the concentration tetracycli~e 
hydrochl(Jride, 
lM] + [T] = constant. 
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The pH of the solu tiori.s was always 5, 8; sodium acetate was used as 
a buffer. The total volume of the mixture of the solutions was always 25 ml, 
and the concentrations of [H] + [T] were varied so. that the concentration of 
[Mj ranged from 0,2 to 1,8. 
1,8 to 0,2. 
The [T] concentration varied correspondingly from 
In the case of titanjum chloride - tetracycline hydrochloride complex, 
the graphs are reproduced below. These w~re obtained from the absorption 
values taken in a Beckman DB-G U.V. spectrophotometer at definite wavelengths, 
e.g. 330 nm and 395 nm. 
From the graphs the M : L ratios were obtained. (See Fig. ~.1, 2, 3.) 
They are as follows: 
Ti - TC.HCl 1 : 1 
CuSO 
4 
- TC .HCl 1 : 1 
Fe SO 
4 
- TC .HCl 1 : 1 
CoSO 
4 
- TC .HCl 1 : 1 
PdC12 - TC.HCl 1 : 1 
Some of these results confirm the ratios obtained by other workers. 
,.3. u.v. Spectrophotometric Studies of the Bathochromic Shifts of the 
Complexes of Tetracycline, Oxytetracycline and Chlortetracycline 
with the Transition Elements. 
In the methods of obtaining absorption curves described in Chapter II, 
the evidence for the formation of a complex of a tetracycline with a transition 
element, rests on the appearance of a pronounced bathochromic shift e.g. 10 - 60 
nm, or the appearance of an absorption curve differing in shape from the 
tetracycline absorption curve concerned and also the transition element 
absorption curve. 
It is well known that temperature may shift ionic equilibria and in 
addition, an increase in temperature will exert a bathochromic shift effect 
on ions in solution i.e. the absorption bands are shifted to longer wavelengths. 
However, all read.ir.gs were taken at 20 CC, and therefore temperature effects were 
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The absorption maxima of the uncomplexed tetracyclines ranged from 
350 to 365 nm. The complexation of the tetracyclines with the transition 
elements, resulted in the absorption maxima having a range from 375 to 425 nm. 
This can be attributed to the formation of single covalent and dative bonds 
between oxygen and the transition element in the complex~which leads to 
further delocalisation of electrons from the conjugated portion of the 
tetracycline molecule and hence to increased stability of the complex. 
In the experimental work performed, a large excess of the metal 
salt was always present to ensure the maximum amount (theoretically lO<YJO of 
the tetracycline complexing and forming a 1 : 1 complex. In the event of. 
any uncomplexed tetracycline being present, duplicate U.V. scanning was 
performed, using the corresponding tetracycline solution as the reference 
sample. 
Absorption curves showing the bathochromic shift due to the 
complexation of the tetracyclines with some transition elements are shown in 
Table 2 .1. In determining the most sui table pH and minimum ·time required 
for stable colour development, it was found titat pH 5,8 using sodium acetate 
as buffer, and thirty minutes was generally suitable. One notable exception 
was the gold - tetracycline complex, which required sixty minutes for the 
formation of a stable colour. 
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CHAPTER IV 
·Formation Constants of Transition Metai-'l'etracycline Complexes. 
4.1. Introduction. 
In Chapter II, the choice of metal ivns for developing a rapid 
analytical method for the estimation of the tetracyclines was discussed. 
In order to assess their efficacy in a quantitative manner, it was decided 
to determine the ~l value for the tetracycline-titanium system. 
An important way to charactnrise complex formation in solution 
is to determine the equilibrium constants of complexes formed. ~evcral 
21 
of the mt~thods used to-day arP. based on curlier work pr~rformr:d by Bodliinder, 
Luther, Abegg and others during the bP.ginning of the century. In moBt 
cases, th~se workers used a large exce1~s of ligund and thP.~ usually had 
only one complex to take into consideration. J. Bjerrum22 was the first 
to emphasize that complex formation generally is a step-wise process. 
These steps may be represented as follows (ch~·ges are omitted for clarity 
of presentation): 
M + L ::::. ML K = ~ ; 4 .1. . 1 L 




4.2. ... (ML] (L] • <: ' ' • • • • • • • • (M~) 
M~-l + L '< ::::.. M~ KN 4. 3 • ' • (~-lj (L] • 
. 
The constants K1 , K2 •••• KN are known as oon~entration or 
stoichiometric step-wise stability constants or formation constants. The 

















•••• K. 1 ' 
•••• KN • 
4·4· 
4 .5 • 
4 .6. 
4. 7. 
In a given solution under specified conditions where two or more 
complexes may co-exis~, the determination of 13i values ~s involved. The 
usual procedure is to follow the idea introduced by Bjerrum22 which utilises 
the determination of correspondin~ values of the formation function, n and 
the free ligand concentration [L]. 
n iS defined as 
-n = Total concentration of ligand bound to metal • ,p 
• ~ - (H3L] - (H2L-] ~L 
2-] - [13-] 
• 
4 .a. 
4 .9 • 
There are many computative procedures which have been devised for 
. p~ocessing the n and [L] data into ~ values, and in the present study the 
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Leden-Fronaeus method is used for processing the potentiometric results. 
In this chapter, derivations are given for expressions for the 
concentration of free.ligand, [i.J, and the formation function, n in terms of 
meas'urable experimental quantities. An exposition of the Leden-Fronaeus 
method of processing n and [L] data to 13 values is given. A description 
ot the potentiometric experimental •thad is included. Application of 
this Mthod to a stud¥ of complexation between tetracycline 8Dd titanium, 
is described. 
4.2. The concentration of free ligand anion, [L] in terms of potentiometric 
measurements. 
We first develop the expression for [L] in terms of potentiometric 
results. The tetracycline molecule contains three dissociable protons and 
we represent it in a simple manner by H
3
L. The potentiometric method used 
' . 22 
her~ is that developed by Bjerrum and Calvin. ~The principle is that upon 
the formation of a complex between a metal ion and the anion of a weakly 
acidic ligand such as H
3
L, protons are released. 
• 4 .1o • 
Clearly the formation of other complexes such as ML2 , ML3 
••• 
is also accompanied by proton release. These pH titration curves obtained 
by titrating H
3
L in the absence and presence of metal [M] ions will be displaced 
from each other. The extent of displacement is related to the formation 
constants of the·M- L complexes. 
The protonation reactions of .H
3








L + H, 
H2L 
:::::::.. HL + H, 




The acid dissociation constants are given by the expressions, 
Kal 
(H2L] (H] • (H
3
L) 
Ka2 - [HL] ~H] [H L 
2 
4 .15. 
and 1<a3 "' ~ • L 4 .16. 
4 .2.1. Titration of ligand in the absence of metal ion. 
If H
3
L, in the absence of M, is titrated aguinst a solution of an 
alkali, in the lower buffer region, we m~ assume lHL] and lL] to be negligible, 
in which case the total ligand concentration, L.r will be given by 
4 .17. 
At any given stage in the titration, we have added a moles alkali 
(e.g. KOH) per mole of ligandt H2L is produced in the following two reactions: 
H
3
L + KOH > H2L + K + H20 4 .18. 
and .. H3L > H2L + H • 4 .19. 
H2L disappears as a result of hydrolysis: 
H2L + H20 ::> H3L + OH • 
Hence [H2L] • aL.r + [H] - ( OHJ • 4 .21. 
The combination of equations 4.14, 4.17 and 4.21 yields 
[H] (a L.r + [H] - (OH] ) 
Kal = -Lr;-=-tat..r + (H] - [OR] ) • 
44 
4.22 • 
In the middle buffer region, we may assume [H
3
L] and [L] to be 
negligible, in which case the total ligand concentration, ~ will be given by 
At any stage in the titration, a moles alkali per mole Qf ligand 
have been added. Of these (a - 1) moles per mole of ligand have been used 
for converting H2L to HL. HL is produced as shown in the following two 
reactions: 
H2L +( KOH ) ) a. - 1. moles 
per mole ligand 
-......;>~ HL and H. 





L + OH. 4.26. 
Hence (HL] = (a.- 1) ~ + [H)- [OR]. 
By combining 4.15, 4.23 and 4.27 we obtain 
Ka2 • 
[H] {(a. - 1) L.r + [H] - (OR] J 
x.r -{(a- 1) L.r + (H]- (OH]l • 4.28. 
In the upper buffer region we may assume [H
3
L) and [H2L] to be 
negligible, in which case the total ·ligand concentration ~' will be given 
by 
L.r .,. [HL] + (L] • 
At any stage in the titration, we have added a. moles per mole ligand. 
Of these (a. - 2) moles of alkali per mole ligand have been used for converting 
HL to L. By using similar arguments to those above, we obtain 
[L] .,. (a - 2) ~ + lH] - (OH] , 
By combining 4.16, 4.29 and 4-30, we obtain 
[H] f(a- 2) ~ + [HJ- [OH]J 




Hence, if they are not already known, values of the acid dissociation 
constants for the ligand may be determined by application. of equations 4.22, 
4.28 and 4. 31. A knowledge is required of the total ligand concentration ~ 
the amount of .alkali added (a mole per mole of ligand) and the corresponding 
hydrogen ion concentration. The last of these quanti ties must be inferred 
from the pH meter reading. .It should be noted that the derivation of 
equations 4 .• 22, 4.28 and 4.31 is based on the assumption that there are large 
differences between the values of Kal, Ka2 and Ka
3
• 
4.2.2. Titration of ligand in the presence of metal ions. 
We now consider the titration of H
3
L in the presence of a known 
quantity of M. The equilibria, 4.1, 4.2 ••••• are involved in the metal-
ligand complex formation. 
The total ligand concentration ~ is now given by the expression, 
~ = [H3L] + (H2L] + [HL] + (L] + (ML] + 2[ML~·J 4.,2. 
The total metal concentration ~ is given by the expression, 
M.r .. [M] + [ML] + [ML2] • 
The total concentration of titratable hydrogen ion is given by, 
and 
From equations 4.14, 4.15 and 4 .• 16: 
[H] +(H2L] 
(H3L] .. Ka2 
[H2L] 
... [H] [HL] 
Ka2 
[HL] = (HJ (L] 
Ka3 • 
Substituting equation 4.37 in 4.19, we obtain • 
[H L] • [H]2[L] 
2 Ka2 Ka3 
and substituting equation 4.38 in 4.35, 
. [H L] = (H]3 (L] 





Now by combining equations4.34, 4.37, 4.38 and 4.39, we obtain 
[Hj - (OH), 
+ ! ' 
which yields the desired expression for [Lj, namely, 
LLJ = 




Kal Ka2 Ka3 Ka2 Ka3 Ka3 
4.41. 
Thus the concentration of .free ligand anion, [L], present in a given 
solution containing the ligand, the metal ion and any given added quantity of 
alkali may be determined by applying equation 4.41; values must be known of 
the total ligand concentration, LT' the acid dissociation constants (Kal, K82 
and Ka
3
), the quantity of alkali added (a mole per mole of ligand) and the 
hydrogen ion concentration. The last of these quantities must be inferred 
from the corresponding pH which has been determined at the respective stage 
in the titration. The value of [OH] may be determined from the relationship 
Kw 
[OH] • 1ii1 
-The formation function, n, in terms of potentiometric measurements. 
We now consider the evaluation of the formation function, n, at any 
stage in the titration with alkali of a solution containing the ligand and 
the metal ion. 
From equation 4 .a, it follows that 
- \t - [H,1] - [~L] - [HL] - LL] 
n • --- - ~ 4 .42. 
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By substituting the expressions for [H
3
L], [H2L] and [HL], namely equations 
4.39,4.38 and4.37 respectively, in equation4 .• 42, we obtain the expression 
-n ,. 
= where 
+ 4 .45. 
Equation 4.44 shows that for any given value of the hydrogen ion 
concentration, as inferred from the measured pH of the.solution, the value of 
n m~y Qe determined from the experimentally accessible quantities, ~· ~' 
Kal, Ka2 and Ka.3 together with the value of [L] calculated acco:tding to 
equation 4 .41. 
4.4. Computation of ~-values from n, (13-J data by the Leden-Fronaeus method. 
It follows from equation 4.8., that 
_ (ML] + 2(ML2] + ••• •• i(MLi j + ••• •• N[M~] 
n = [M] + (ML] + ..... [MLi] + ..... (M~] 
By introducing equations 4.1 - 4.7 we obtain 
f31 [M][L] + 2f32[M][Ll + ••••• il'i (M][Ll ••••• Nf:iN(M][Lf 
LM] + ~1 [Mj[Lj + ••••• "1 [M][L]i • • • • • f3N[M][Lf 
. . 
·(· 1 + L ".i lL]i) 
i .. 1. 
Fronaeus introduced the function, 
N 
L . i X = 1 + ~ [L] - i ' 
i = 1 





By differentiation of equa.tion4.47, we obtain, 
dX . · ·2 
d[LJ = ~1 + 2~2[1j + 3~3(1] + 
.. 
• • 
. L i~i LL]i-1 • 
[LJ(~11) ·I1~1E1i • 
From equation 4.48; 
-n = [L] (~jLJ) 
dl X n 
X 
Integrating equation 4.51., 
(L]i 






Thus, by plotting [~) vs. [L], extrapolating the curve ·to [L] • 0 
and graphically integrating from lL] • 0 to any given value lLJ = [L]i, we 
obtain the value of ·enx corresponding to [L] = [L]1• The principle involved 
is illustrated j,n Pfg.4~4~Iwhich is a. sketch showing a. typically shaped 
n vs. LL] curve. It is clear that provided the extrapolation of the curve 
m 
to [L] • 0 can be carried out reliably, there is no difficulty in graphically 
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-
integrating the function [~] with respect to [L], successively between 
lL] ,= 0 and lL] = [1]
1
; (L] • 0 and (L] = lL]
2
; ••••••••• (Lj = 0 and 
[L] '= [L~ where [L] = [L~ o~curs at some arbi tracy convenient point where 
the curve flattens. 
Fig.· 4 .{,.1. 
-n. 
LL1 
[1]1 (1]2 (1]3 · [1]4 
[L) 
-
Sketch showing [~] as a function of [L] for the step-wise formation 
of complexes, ML, ML2 ••••••••• M~. 
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Hence, we obtain a set of experimental X, [L] values. We process 
the X vs. lLJ data as follows: Fronaeus introduces the further function, X1, 
defined by 
• 
Thus for every X, [L] value, a pair of values, x1 , [L] may be 
calculated from the experimental data. 
But, by introducing equation 4.•47, we see that 
• 4 .53 • 
Therefore,· if the values of x1 are plotted against '{L], a curve is 
obtained with an intercept on the lLJ • 0 axis equal to ~1 • 
evaluated by determining the intercept~ 
Thus ~l may be 
Next, we consider the Fronaeus function, x2, defined by 
... (Xl - ~1) (L] • 
Similarly, several pairs of values, x2, [L], may be calculated from 
the experimental x1, lL] data. When these are plotted, they also form a curve. 
from equation 4.• 53 and the definition of x2, we see that 
· ( J l -N-2 X2 = ~2 + ~3 L + ••••• ~N Lj • 
It follows that the value of ~2 may be determined by estimating the 
intercept of the x
2 
vs. [L] curve.. .The procedure continues in an analagous 




vs •. [L] ••.• ~ vs. [L] are· 
plotted, where in general 
• 4. 55 • 
But, since xj ... ~j + ~j+l LL] •••••• 
of the intercept 
r:s j. Eventually 
of each Xj vs~ [Lj curve gives us an estimate of the value of 
a curve, ~-l vs. [L] will be obtained which will be linear 
with intercept equal to ~k-l and slope r:sk. Hence, when the points ~' [L] are 
plotted, they will be best represented by a straight line of zero slope: each 
value of~ will then give an additional estimate of r:sk and, indeed, the 
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value of k should represent N, the maximum co-ordination number of the metal 
with respect to the ligand concerned. The sketches of Fig. •· 4.2 'illua.trate 
the Xj' lL] curves diagrammatically for the case of k ... N • 3. The curve (a) 
of x1, [L] would be curvilinear and the intercept would yield the value of ~1• 
The points, ~' [L] would form a linear plot, (b), with intercept equal to ~2 
and slope equal to ~3 • The ~alue of ~3 would be confirmed by evaluating x3 
for several values of [L]; the x
3 
values would be more or less constant, 
except for experimental scatter (Fig-4.4•2(~)), and should approximate to the 





Sketch showing Xj plotted against 
(L] for the case of the formation 
of 3 complexes, ML, ML2 and ML3
• 
(N • k • 3) 
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. 4.. 5. Experimental. 
The Bjerrum-Calvin potentiometric method for determining ~-values. 
4. ~.1. Principles Underlying the Method. 
The potentiometric titration of a polyprotic ligand with a strong 
base (e.g. KOH) will produce a titration curve with a shape which will depend 
upon the relative magnitudes of the various dissociation constants. In the 
case of a diprotic ligand, if the difference between the primary and secondary 
dissociation constants is large, the solution behaves like a mixture of two 
monoprotic acids with dissociation constants K1 and K2 respectively. When 
however, a solution of a metal salt is added to a ligand solution and 
complexation occurs, then when the mixture is titrated against a atrong base, 
the inflections are displaced aa shown .in fig. 4.5.1.1. The amount of the 
displacement affords a means of determining the formation constants of the 
complexes. (The theory is outlined in sections ~1 - ~.3.) 
pH 
------- ligand ligand-metal complex 
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Volume alkali added 







4.5,2. The Beckman Electroscan Automatic Apparatus. 
A Beckman 'Electroscan' was used for the production of titration 
curves• The instrument is a self-contained, electro-analytical system 
capable of performing fifteen measurements in the two main categories of 
potentiometry and voltammetry. Requiring only the use of proper cells and 
electrodes, the instrument is versatile, convenient and economical for 
laboratory use. The instrument consists of a high-speed, high impedance 
potentiometric recorder, and an electrolysis module that incorporates a high-
gain operational amplifier with circuits for either controlled current or 
controlled voltage mode of operation. 
The electro-analytical measurements performed by the instrument 
include 
1. pH recording 
2. Millivolt (and O.R.P.) recording 
~. Potentiometric titrations 
4. Chronopotentiometry 
5. Coulometric titrations 
6. Electrodeposition 
1. Stripping analysis 
8. Controlled voltage coulometry 
9. Chronoamperometry 
10. Electrodepoaition and separation 
11. Three electrode polarography 
12. Solid electrode voltammetry 
13. Potential sweep chronoamperometry 
14. Cyclic voltammetry 
15. Anodic stripping voltammetry 
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The Manual Procedure. 
In order to assess any inherent errors in the Electroscan method of 
producing titration curves, a manual method was used to produce data which could 
be reproduced in graphic form. The method was similar to the Electroscan 
method, except that a Beckman pH meter was used and the titrant was added .in 
sm~ll definife increments, while the mixture was stirred with a magnetic stirrer. 
Glass and calomel electrodes were used in the titration vessel. The final 
volume was the same after titration (50 ml) and the latter was performed in an 
atmosphere of nitrogen. 
Experimental Details. 
A special motor-driven burette containing the 1 M potassium hydroxide 
solution was then clamped in position above the beaker and its tip placed below 
the surface of the liquid in the beaker. The delivery rate of the burette was 
carefully measured and adjusted so that 1,00 ml was delivered every 150 seconds. 
The Electroscan was set for the pH 0- 14 mode of operation, and a suitable 
chart speed of 50 sec./inch was chosen. Using four buffer solu~ions, the 
instrument was standardised before the titration& were commenced. The mixture 
in the beaker was stirred with a magnetic stirrer. The potassium hydroxide 
solution was carbonate. free~4 The total volume after titration. was always 
the same i.e. 50 ml. The amount of alkali used for eaeh titration was 5 ml. 
Tetracycline hydrochloride, in the absence of metal ions and in the 
presence of one, two and three equivalents respectively of titanium trichloride 
was titrated with 1M potassium hydroxide. 
4.6. Results. 
4,.6.1. Potentiometric results. 
The potentiometric titration of tetracycline with potassium hydroxide 
solution produced a curve with two clear inflections, corresponding to two 
separate neutralisation reactions (Fig. 4.6.1.1.) 
Table 4.1. shows the· calculated values for [13-] t ii 'and t ~· 
. L -] 
for the pH range 1,6 to 7 ,o applied to .the titanium-tetracycline .complex 
system. The calculations used to obtain these results were described in 
section 4-4 of this chapter. The pKa values for tetracycline obtained. by 
1. V. Dmi trienko et all3 are as follows 
pK~ • 3,30 
pK~ • 7,68 
pKa3 • 9,69. 
The [13~] and ii values in table. %1. were baaed on these figures. 
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Graph showirtg.po1;entiometric. titr.ation of tetracycline hydrochloride with 
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Moles 0,1 M KOH · i · .. 
~' ·' . 
;.-,·, 
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-. - n Values for the formation funct~o~ n, TLJ' and the ligand ion concentration 
[13-J at different pH values. 
[13-J 
-
pH - n n m 
1,6 3,124 X 10-lS 0,26 8,322 X 1016 
1,8 6,97 X 10-lS 0,282 4,046 X 1016 
2,0 2,973 X lO-l7 0,238 8,005 X 1015 
2,2 9,147 X 10-l7 0,383 15 4,188 X 10 · 
2,4 2,478 X 10-l6 0,651 2,627 X 1015 
3,0 1,05 x lo-14 0,934 8,894 X 10l3 
4.7 4,762 X 10-ll 0,753 1,581 X 10
10 
5,7 1,078 X 10-ll 0,996 9,239 X 10
10 
7,0 3,635 X 10-6 0,45 
.. 5 
1,238 X·lO 
The values for the hydrogen ion concentration [H] us~d in the 
calculation (equation 4.41.) were approximate as the activity coefficient 
of the hydrogen. ions was presumed to be unity. n was calculat,ed using 
equation 4·44 and [13""] was calculated using equation 4 .41. In the latter 
calculation, the value of [OH] was disregarded as it was so small (e.g. 
-12 ) 10 etc. • The relationship is shown by the equation 
(H] x (OH] ? K · • l0-l4 • 
' w 
-
Fig. 4 .;6.L2 qhows the values of ~ of .table 4 •. 1. plotted against 
• . [1 -] 
[13-J-. The best curve drawn by inspection through the points and extra-
polated to [13-]:• 0, was integrated graphically for several equally spaced 
[13-J values in order to calculate X values by the procedure outlined in 
section 4 .5. The values obtained are listed in table 4.2-. 
.6.1.2. fig.~ - ----
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Table 4. ~. 
Values of the function X for various values of [13-) obtained by graphical 
integration of Fig. 4. 9.1.2 for the titanium-tetracycline system. 
[13""] X 










As shown in section 4.5 of this chapter, the new function x1 was 
··defined as follows: 
= • 
Hence from the X values in Table 4. 2, x1 values we're calculated 
for the same set of [13-] values. These are listed in. Table 4 .. 3· 
Except for the values corresponding to the two lowest ligand concen-
trations, x1 appears to be more or less constant. The apparent anomalous 
differences of the two former results probably arises from uncertainty in th~ 
extrapolation of the curve in Fig. 4.6 .• 1.2. If we assume x1 to have a constant 
value in the concentration range of 1, considered, it follows that only a 1 : l 
metal : ligand complex has been formed .in the conditions used for this study 
{refer to secti.on 4 .5). The formation constant, r-;1, for this complex wiil be. 
estimated as the average of the x1 values (exc·luding the first t~o of Table 4•3) 
namely: 3,4 x 1015 M-1• 
Table 4!l• 
f . ( X - 1) [ 3- J-Values o the funct1on x1 = 3 for various values of L for the . [L - J 
titanium-tetracycline system. 
[13- J X ... 1 X 1 
X 10l7 X 10l7 
2,0 - 0,178 - 0,089 
4,0 0,048 0,012 
6,0 0,166 0,0276 
8,o 0,266 0,033 
.10,0 0,348 0,0348 
12,0 0,428 0;035 
14,0 0,508 0,036 
16,0 0,578 0,036 
18,0 0,638 0,035 
20,0 0,698 0,035 
Average of the x1 values > ~1 = 3,4 X 10
15 M""l 
4·1· Discussion. 
The hisb value obtained for the stability constant ~l show in 
section 4.6 usin« the potentiometric method indicates the stable nature 
60 
of the metal-tetracycline complexes stud~ed. In order to develop tbe rapid 
spectrophotometric aethod of analysis, fUrther studies of the foraation 
constants of metal-tetracycline ion aysteu tosether with the aethoda 
involved, is required. In particular, it is recommended that a supporting 
electrolyte 'be used for maintainiDC constant-iouic streqtll, 1a order fo 
suppress fluctuations in the value• ot the acttnv~coetficients of * 
reactinc species. Ia appqiJia the potentiometric· ..tb.od it would also be 
aore effioacioua to develop a aore precise relatiODBid;p be~ea [B+] q.c1 ~e . 
pB aeter reaAiq, thaD has been uaecl iii this work. 
61 
However, the higb result obtained for the stabilit.y constant 
endorses the method chosen for the spectrophotometric assa, of tetracycline 
products as described in section 2.2. Although many transition metals 
form complexes with the tetracyclines, not all of these complexes have 
sufficiently sharp absorption peaks to qualify for use as a reliable means 




Complexes of those transition elements with the tetracyclines 
hitherto not reported in the literature, have been fully described in 
Chapters II,and. III. 
The transition elements are metals of high melting point and possess 
typical metallic properties. The atomic structur~of the transition elements 
are characterised by the presence of d orbitals in the penultimate shell of 
electrons which are capable of taking part in bond formation. Non-trans! tion 
elements do not possess this property. 
In any series of transition elements, the real nuclear charge increases 
by unity; the screening constant, however, increases only by the value appro• 
priate to a d electron in a penultimate shell; and this v~ue is less than 
unity. Hence the effective nuclear charge increases with increase in atomic 
number and consequently the atomic radii and the ionic radii for successive 
26 
ions of the same ionic valency, decrease along the series.· · 
The ultraviolet spectra of the complexes of the transition metals 
possess certain characteristics which have been ascribed to the separation 
of the d orbitals of the metal into two sets, due to the splitting of the 
formerly degenerate energy into two distinct values. ·This splitting is due 
to the electric field exerted by lone pairs of electrons in the tetracycline 
ligands. . The tetracycline ligand is a large one and hence ·the existenee 
of several pairs of lone electrons is possible. 
Intensive study of cobalt (II) and nickel (11) complexes with 
oxytetracycline have shown that they are octahedral? · In this ·case, those d 
atomic orbitals of the transition metal whose wave functions lie mainly along 
the diagonals between the axes (t2g orbitals) will have a lower energy than . 
the e orbitals (the wave functions which lie on the axes x, y and z). The 
g .. 
strength of the ligand (tetracycline) is indicated by~ , which represents 
6} 
the separation in energy between the t 2g and the eg atomic orbitals of the 
transition metal concerned. 
The tetracyclines are used in medicine for their anti-bacterial 
activity. The actual mechanism of this effect has not yet been definitely 
established. It does appear however, to be linked to the ability o£ the 
tetracycline molecule to form . complexes with a large variety of metal ions 7 
The important question - which specific group, the tetracycline uses to bind 
the metal has not been established with certainty. 
By comparing the effects of metal ions on the U.V. absorption 
spectrum, specifically the absorption at 370 nm, of oxytetracycline, with 
27 the corresponding effects of the same ions on model compounds, Conover· , has 
concluded that the linking group is the enolized ~-diketone group at c11 and 
c12• 
The list of those transition elements which complex with.the 
tetracyclines and have hitherto not appeared in the literature, .fa given in 
Chapter II together with the amount of bathochromic shift obtained from the 
u.v. absorption curve. 
I 
The study of the complexation of the three;tetracyclines, tetra-
cycline, oxytetracycline and chlortetracycline with the transition elements 
has shown that twenty-eight transition metals form complexes with the 
tetracyclines. 
Several of these elements would prove to be effective in the 
quantitative estimation of the tetracyclines using u.v. speotrophotomet~. 
The following transition elements are especially recommended for several re~ons. 
They may be stored in solution form for several months without deterioration; 
they form stable complexes rapidly with the tetracyclinesa the bathochromic 
shift is fairly substantial. 
1. Coppe~ (sulphate) 
2. Thorium (nitrate) 
3. Uranium (nitrate) 
Investigations have been conducted showing the metal ligand ratio 
of some of these complexes and confirming the results reported in the literature. 
The stability constant of titanium- tetracycline complex has been ascertained 
I 
by the pc)tentiometric ~~ethod. 
The advantage.of the spectrophotometric method is the amoUnt of time 
it would save in performing a quantitative assay compared to' the current micro-
biological method of assay. The accuracy of the spectrophotometric method of 
assay compares very favourably with the results obtained by microbiological 
assay of all the tetracycline products examined. 
Further work remains to be done on the difficult problem of 



























LIST OF SYMBOLS 
Stability constant. 
Difference between the mean effect for a particular 
row and the grand mean. 
Difference between the mean effect for a particular 






Buaber of rows in plate agar assqs. 
LigaDd. 
Total ligand concentration. 
Met&l • 
Metal-ligand complex • 
T.otal aetal ion concentration. 
Nanoaetre i.e. 10-9 metre. 
Total concentration of ligand bound to aetal 
M.r 
Total nuaber of dilutions used. 
Solvent molecule; standard preparation of Tetracycline 
Hydrochloride. 
65 
Low strength standard solution of Tetracycline Hydrochloride. 
Medium strength standard solution of Tetracycline 
Hydrochloride. 








Low strength Tetra.Cyclirie soi\ltion. 
· MediWI s~rength Tetracycline solution. 
.·High. strength Tetraeycline solution. 
·' 
' . . . . 
•lMJ + lMAJ + tMA2. J where M represents tnetal.. ana . A the acidic ligand. 
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APPENDIX 2. -
PREPARATION OF SOLUBLE SALTS OF THE TRANSITION ELEMENTS. 
The rarer elements such as Plutonium, Americi~Curium and 
Berkelium were not available. However, forty-one transition elements 
were procured in various forms; pure element, oxide, chloride, nitrate etc. 
Those elements occurring in the pure state or as oxides, required 
special treatment.in order to obtain a soluble chloride, nitrate or sulphate 
etc. 
Experimental. 
De-ionised water was used throughout this work. 
Vanadium was obtained as vanadium ~ntoxide V 2o5, a yellow brown 
crystalline substance. The vanadium pentoxide was dissolved in a small 
amount of hydrochloric acid, and then diluted with water to form a 0,01 · M 
solution. 
Yttrium was obtained as yttrium oxide, Y2o3 
in a fine white powde~. 
This was dissciLted in dilute hydrochloric acid and diluted with water to form 
a o,Oli M solution of yttrium chloride YC1
3
• 
N.iobium was available as niobium pentoxide, Nb2o5• 
The penta-
chloride was made by heating niobium pentoxide with excess of carbon tetra-
chloride at a temperature of 270~ under pressure for one hour. The niobium 
chloride Nbcl5 .formed however, decomposes easily in the presence of water and 
therefore this element proved unsatisfactory for assaying tetracyclines. 
Molybdenum was obtained_ as molybdenum trioxide, Moo
3
• This was 
dissolved in a small amount of hydrochloric acid and diluted with water to 
form a 0,01 M solution. The exact composition of this solution of 
molybdenum chloride is unknown; it is possibly Moc16• 
Technetium. A dilute solution of techne.tium chloride was prepared 
at Groot,e Schuur Hospital in a special generator. A molybdenum salt solution 
wa.S poured onto an ion exchange column and the latter submitted to bombardment 
by neutrons for some time. The column was then eluted with dilute sodium 
chloridesolutioil..and a radioactive solution of the daughter element technetium 
was obtained. ._The, solution was kept in a le8d-shielded bottle for a period of 
five days~- arter which the radioac ti vi ty was negligible and the solution of 
technetium chloride Tec1
4
, could be used with safety. 
Lanthanum was obtained as the oxide 1~03 , a cream white amorphous 
powder. This was heated with dilute hydrochloric aeid until a solution was 




Tantalum was available as the pentachloride, TaC15• On dissolving 
in water, it decomposed slowly however, and was found to be unsuitable for 
complexation with the tetracyclines. 
TungSten was obtained as the hexachloride wc16, a dark crystalline 
brown solid. This .was dissolved in dilute hydrochloric acid and diluted 
with water to form a 0,01 M solution. 
Rhenium was obtained as the heptoxide Re2o7, a dark yellow-green 
crystalline substance. This was freely soluble in water and required no 
preliminary treatment. 
Praseodymium was obtained as the oxide Pr2o3, a brownish black fine 
powder. This was dissolved in dilute hydrochloric acid by-gently heating to 
form the chloride Prel
3
• 
form a 0,01 M solution. 
This green solution was then diluted with water.to 
Neodymium was available as the oxide Nd2o3, a faint ma.uve-whi te 
powder, almost insoluble in water. This was dissolved by gently heating 
in dilute hydrochloric acid and then diluted with sufficien~ water to form a 
0,01 M solution. 
·, 
: · Samarium was available as the oxide Sm2o3, a yellowish white .Powder. 
This wasdissplved in hydrochloric acid to form the chloride Smc1
3
• The 
solution was evaporated to dryness on a waterbath and the excess hydrochloric 
acid removed. The residue was dissolved in a little dilute hydrochloric acid 
and diluted with water to form a 0,01 M solution. 
Europium was available as the oxide Eu2o3, a pink•white powder. 
This was dissolved in concentrated hydrochloric acid to form the chloride, 
The solution was eyaporated on a waterbath to remove the excess 
hydrochloric acid. 
·~ 
The residue was then dissolved in dilute hydrochloric acid 
and diluted with water to produce 0,01 M solution. 
Terbium was obtained as the oxide, Tb2o3, a dark brown crystalline 
substance. This was dissolved in hydrochloric acid, filtered, and the 
filtrate evaporated to dryness on a waterbath. The residue was dissolved 
in water to produce a 0,01 M solution of terbium chloride, TbC1
3
• 
Dysprosium was available as the oxide ny2o3, a fine white, 
crystalline substance. Th~ oxide was dissolved in a small amount of hydro-
chloric acid by heating and diluted with water to form a solution containing 
0,01 M of the chloride Dycl
3
• 
Holmium was obtained as the oxide Ho2o3, a yellow white powder. 
This was dissolved in a small amount of hydrochloric acid by gentle heating, 
and diluted with water to form a solution containing 0,01 M of the chloride, 
Erbium was obtained as the oxide, Er2o3
, a pink, fine powder. 
This was dissolved in dilute hydrochloric acid and diluted with water to form 
a 0,01 M solution of erbium chloride, ErC1
3
• 
Tellurium was obtained as the oxide Teo2,. a white crystalline 
substance. This was dissolved in hydrochloric acid and evaporated to dryness 
on a waterbath. The residue was dissolved in a small amount of hydrochloric 
acid and diluted with water to form a solution of 0,01 M tellurium chloride, 
TeC1
4
• This solution decomposed slowly and was round to be unsuitable for 
complexation with the tetracyclines. 
YtterbiUm was available as the oxide Yb2o3
, a white crystalline 
substance.. This was dissolved in a small amount of hydrochloric acid and 
di.luted with water to form a 0,01 M solution of Ytterbium chloride YbCl
3
• 
Lutecium was available as the oxide, Lu2o3, a white fine powder. 
This was dissolved in a little hydrochloric acid by warming, and diluted 
with water to form a 0,01 M solution of the chloride, Luc1
3
• 
The remaining transition elements were easily available as chlorides 
and sulphates (A.R.), and these were readily soluble in water. 
-~-----~---------
Notes. 
Mould growth was observ~d.insome solutions of the transition eleillen' 
salts after a few days, and fresh solutions were subsequently prepared, using 
sterile de-ionised water and sterile beakers for the preparations of solutions_. 
Some solutions, after a few days, showed signs of hydrolysis forming 
a precipitate e.g. zirconium sulphate. Where this occurred, only freshly 
prepared solutions were used for the complexation experiments. 
APPENDIX 3. 
U. V. SPECTROPHOTOMETRIC ABSORPI'ION CURVES OF SEVERAL 
TRANSITION METAL - TETRACYCLINE COMPLEXES TOGETHER 
WITH CALIBRATION GRAPHS OBTAINED FROM THESE CURVES. 
ll 
Tetracycline HCl Fig.A.3.1. 
+ 
Chromic Chloride 
pH 5,8 R-H20 
WAVELENGTH (nm) 
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Tetracycline HCl Fig.A.3.3. 
+ 
Neodymium Chloride · 
pH 5,8 R-H20 
WAVELENGTH (nm) 












T et racyc line HCl 
+ 
Nickel Sulphate 
R-H 0 2 
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Tetracycline HCl Fig.A.3.5. 
+ 
Praseodymium Chloride 
pH 5,8 R-TCl, HCl 
,40 
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pH 5,8 R-H20 
WAVELENGTH (nm) 
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Tetracycline HCl Fig. A. 3.8. 
+ 
Zirconium Sulphate 
pH 5,8 R-H20 
WAVELENGTH (nm) 
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Fig.A. 3. 9. 
Chlortetracycline HCl . 
+ 
Cadmium Chloride 
pH 5,8 R~H20 
Calibration 1 
WAVELENGTH (nm) 






























PH 58 R-H 0 ,lO • . 2 
Calibration 2 · 
WAVELENGTH (nm) 





pH 5,8 R-H20 
Calibration 3 
WAVELENGTH (nm) 
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Calibration 4 
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pH 5,8 R- H20 
Calibration 5 
WAVELENGTH (nm) 
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m / Calibration GraP-h <( 
C hlortet racy eli ne 
0,21- /./ + Cadmium Chloride 
0,1 t- Fig .A.3.14. 
CONCENTRATION f..IQ/ml CHLORTETRACYCLINE . 
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Cupric Sulphate 010 , 
pH 5,8 R-H20 
Calibration 1 
WAVELENGTH (nm) 
500 400 300 200 
Fig.A. 3.16. 
.0,7C 













pH 5,8 R- H20 ,10 
Calibration 2 
WAVELENGTH (nm) 















pH 5,8 R-H20 . ,10 
Calibration 3 
WAVELENGTH. ( nm) 

















pH 5,8 R-H20 0,10 
Calibration 4 
WAVELENGTH (nm) 















pH 5,8 R- H20 0,10 
Calibration 5 
WAVELENGTH (nm) 
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Fig .A .3.20. 
CONCENTRAliON .,ag/ml CHLORTETRACYCLINE 
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pH 5,8 R-H20 · 
Calibration 2 
WAVELENGTH (nm) 
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Fig .A. 3~23. 
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pH 5,8 R- H20 . 0,10 
Calibration 4 
WAVELENGTH (nm) 
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Chlortetracycline HCl 
+ 
Praseodymium Chloride . 
pH 5,8 R -H20 
Calibration 5 · 0,10 
Fig .A.3.25. 
WAVELENGTH (nm) 























CONCENTRATION IJg/ml CHLORTETRACYCLINE 
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Chlortetracycline HCl · 
+ 
Uranyl Nitrate 
pH 5,8 R- H20 ,10 
Calibration 1 
WAVELENGTH (nm) 
500 400 300 ·.··200 
Fig .A. 3. 28. 














0 Chlortetracycline HCl 
+ 
Uranyl Nitrate 
pH 5,8 R-H20 
Calibration 2 
WAVELENGTH (nm) 
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. pH 5,8 R- H20 
Calibration 3 
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Oxytetracycline HCl · 
+ 
Cadmium Chloride 
pH 5,8 R-H20 
Calibration 1 
WAVELENGTH (nml 
500 400 300 200 
Fig.A. 3. 34. 
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Cadmium Chloride · 
pH 5,8 R- H20 0.10 
Calibration 2 
WAVELENGTH (nm) 
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Fig.A. 3.35. 
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pH 5,8 R- H20 · 0,10 
Calibration 3 
WAVELENGTH (nm) 
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F ig.A. 3. 36. 














pH 5,8 R- H20 0,10 
Calibration 4 
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• Oxytetracycline + 
Cadmium Chloride 
f!ig.A .38. 
O. _ CONCENTRATION J.J g/ml OXYTETRACYCLINE 








































pH 5,8 R-H20 
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Fig .A.3.L.O. · 
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Fig .A_, 3.!.3. 





















. ·· CONCENTRATION tJQ/ml OXYTETRACYCUNE 
QV- ·. I I . .. . I . . . I I 
0 5 10 15 20 25 
Fig.A.3.45. 
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Oxytetracycline HCl i + 0 4~ ' 
Praseodymium Chloride w 
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pH 5,8 R-H 0 2 
Calibration 2 
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Fig .A. 3.48. 
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pH 5,8 . R- H20 0,10 
Calibration 4 
WAVELENGTH (nm) 
















Praseodymium Chloride . 
pH 5,8 R- H20 · ,10 
Calibration 5 · 
WAVELENGTH (nm) 
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Tungsten (VI) Chloride 
pH 5,8 R- H20 0,10 
Calibration 1 
WAVELENGTH (nm) Fig .A.3.51. 

























Tungsten (VI) Chloride 
pH 5,8 R- H20 . 0,10 
Calibration 3 
Fig .A. 3. 53. 
WAVELENGTH ( nm) 
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Oxytetracycline HCt · 
+ 
Tungsten (VI) Chloride 
pH 5,8 R- H20 0,10 
C atibration 5 
WAVELENGTH (nm) 
Fig .A.3. 55. 
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pH 5,8 R- H20 
Calibration 3 
WAVELENGTH (nm) 















pH 5,8 R-H20 
Calibration 4 
WAVELENGTH (nm) 
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pH 5,8 R-H20 
Calibration 2 
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Oxyt~tracycline HCl sol. 
. pH 5.8. 
R-H20 
Fig. A. 3. 67. 
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Fig. A .3. 68. 
Tetra.cycline HCl Solution 
pH 5,8 R·H20 
WAVELENGTH (·nm) 
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